Merit Medical Systems (NASDAQ:MMSI) Announces Earnings Results, Beats Estimates By $0.11 EPS

Merit Medical Systems (NASDAQ:MMSI) announced its quarterly earnings data on Tuesday. The medical instruments supplier reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.11, Zacks reports. Merit Medical Systems had a return on equity of 15.61% and a net margin of 9.05%. Merit Medical Systems updated its FY 2025 guidance to 3.580-3.700 EPS.

Merit Medical Systems Stock Performance

Merit Medical Systems stock traded down $1.46 during mid-day trading on Tuesday, hitting $102.05. 783,463 shares of the company’s stock traded hands, compared to its average volume of 515,152. Merit Medical Systems has a one year low of $70.70 and a one year high of $111.45. The company has a market cap of $5.95 billion, a PE ratio of 50.02, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. The firm has a 50 day moving average price of $102.66 and a 200 day moving average price of $99.81. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on MMSI. Barrington Research raised their price objective on Merit Medical Systems from $114.00 to $115.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 29th. Piper Sandler restated an “overweight” rating and issued a $116.00 price target (up from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Needham & Company LLC boosted their price objective on shares of Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Raymond James increased their price objective on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 31st. Finally, Canaccord Genuity Group lifted their target price on Merit Medical Systems from $127.00 to $128.00 and gave the company a “buy” rating in a research note on Wednesday, January 29th. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $109.80.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.